Django Andrews currently holds the position of patent counsel at Nektar Therapeutics in San Francisco where he engages in a wide variety of intellectual property matters including patent portfolio development and evaluation. Django has experience in patent preparation, prosecution and portfolio management, patentability and freedom-to-operate opinions, patent due diligence, and patent licensing. He also has experience in trademark preparation and prosecution.
Django holds a Ph.D. in chemistry from the University of Colorado where he studied the structure of gas phase ions with W. Carl Lineberger in the JILA institute. Before joining Nektar Therapeutics, he worked at what is now the Boulder, Colorado office of Lathrop & Gage LLP, as well as in the San Francisco and Palo Alto offices of Squire Patton Boggs (US) LLP. Django is also a member of the advisory board of NeuroSave, Inc., a 2014 FAST program graduate company.